Literature DB >> 12845424

Assessment of bone mineral density in adults and children with Marfan syndrome.

Philip F Giampietro1, Margaret Peterson, Robert Schneider, Jessica G Davis, Cathleen Raggio, Elizabeth Myers, Stephen W Burke, Oheneba Boachie-Adjei, Charles M Mueller.   

Abstract

Recent studies indicate that decreased bone mineral density (BMD) occurs in the spine, femoral necks and greater trochanters of some adults and children with Marfan syndrome. Because there is uncertainty regarding the BMD status of patients with Marfan syndrome, we undertook an analysis of BMD in both adults and children with Marfan syndrome. Dual energy X-ray absorptiometry analysis was performed on a convenience sample of 51 patients (30 adults and 21 children) with diagnosed Marfan syndrome from 1993 to 2000. T-Scores (i.e. the number of standard deviations above or below the average normal peak bone density) were determined for comparison of adults. Mean+/-SD of individual BMD values were used for comparison of the data of children. Compared to standard values obtained from normal adult patients, adult males with Marfan syndrome demonstrated significantly reduced femoral neck BMD with an average T-score of -1.54 ( P<0.001), diagnostic of osteopenia. Although osteopenia and osteoporosis were observed in several middle aged and pre- and postmenopausal women, the average T-score value for adult females and children were within normal limits. The etiology and full significance of decreased BMD in adult male patients with Marfan syndrome remain uncertain at the present time. Our results lead us to question the value of aggressive BMD evaluations by DXA in these patients, particularly prior to reaching mid-age. Further investigations will be required to shed insights into the natural history of BMD in adults and children with Marfan syndrome. Any application of bone mineral replacement therapy such as bisphosphonate, selective estrogen receptor modulators, hormone replacement therapy and vitamin D in these patients may be premature based on the existing evidence.

Entities:  

Mesh:

Year:  2003        PMID: 12845424     DOI: 10.1007/s00198-003-1433-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  16 in total

Review 1.  Interpretation of absorptiometric bone mass measurements in the growing skeleton: issues and limitations.

Authors:  D A Nelson; W W Koo
Journal:  Calcif Tissue Int       Date:  1999-07       Impact factor: 4.333

2.  Total-body and regional bone mineral content and areal bone mineral density in children aged 8-18 y: the Fels Longitudinal Study.

Authors:  L M Maynard; S S Guo; W C Chumlea; A F Roche; W A Wisemandle; C M Zeller; B Towne; R M Siervogel
Journal:  Am J Clin Nutr       Date:  1998-11       Impact factor: 7.045

3.  Revised diagnostic criteria for the Marfan syndrome.

Authors:  A De Paepe; R B Devereux; H C Dietz; R C Hennekam; R E Pyeritz
Journal:  Am J Med Genet       Date:  1996-04-24

Review 4.  The Marfan syndrome: diagnosis and management.

Authors:  R E Pyeritz; V A McKusick
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

Review 5.  Fibrillin-containing microfibrils: structure and function in health and disease.

Authors:  C M Kielty; C A Shuttleworth
Journal:  Int J Biochem Cell Biol       Date:  1995-08       Impact factor: 5.085

6.  Assessment of bone mineral density in women with Marfan syndrome.

Authors:  J H Tobias; N Dalzell; A H Child
Journal:  Br J Rheumatol       Date:  1995-06

7.  Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study.

Authors:  P Tsipouras; R Del Mastro; M Sarfarazi; B Lee; E Vitale; A H Child; M Godfrey; R B Devereux; D Hewett; B Steinmann
Journal:  N Engl J Med       Date:  1992-04-02       Impact factor: 91.245

8.  Bone mineral status of women with Marfan syndrome.

Authors:  L Kohlmeier; C Gasner; R Marcus
Journal:  Am J Med       Date:  1993-12       Impact factor: 4.965

9.  The bone mineral status of patients with Marfan syndrome.

Authors:  L Kohlmeier; C Gasner; L K Bachrach; R Marcus
Journal:  J Bone Miner Res       Date:  1995-10       Impact factor: 6.741

10.  Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake.

Authors:  K O Musgrave; L Giambalvo; H L Leclerc; R A Cook; C J Rosen
Journal:  J Am Diet Assoc       Date:  1989-10
View more
  10 in total

1.  Hand and foot abnormalities associated with genetic diseases.

Authors:  Henry J Mankin; Jesse Jupiter; Carol Ann Trahan
Journal:  Hand (N Y)       Date:  2010-10-26

2.  Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.

Authors:  Harikiran Nistala; Sui Lee-Arteaga; Luca Carta; Jason R Cook; Silvia Smaldone; Gabriella Siciliano; Aaron N Rifkin; Harry C Dietz; Daniel B Rifkin; Francesco Ramirez
Journal:  Hum Mol Genet       Date:  2010-09-24       Impact factor: 6.150

3.  Spinal fusion in pediatric patients with marfan syndrome: a nationwide assessment on short-term outcomes and readmission risk.

Authors:  Michael W Fields; Nathan J Lee; Jacob R Ball; Venkat Boddapati; Justin Mathew; Daniel Hong; Josephine R Coury; Zeeshan M Sardar; Benjamin Roye; Michael Vitale; Lawrence G Lenke
Journal:  Eur Spine J       Date:  2020-10-19       Impact factor: 3.134

4.  Fibrillin-1 Regulates Skeletal Stem Cell Differentiation by Modulating TGFβ Activity Within the Marrow Niche.

Authors:  Silvia Smaldone; Nicholas P Clayton; Maria del Solar; Gemma Pascual; Seng H Cheng; Bruce M Wentworth; Mitchell B Schaffler; Francesco Ramirez
Journal:  J Bone Miner Res       Date:  2015-08-17       Impact factor: 6.741

5.  Bone mineral density determinations by dual-energy x-ray absorptiometry in the management of patients with Marfan syndrome--some factors which affect the measurement.

Authors:  Philip F Giampietro; Margaret G E Peterson; Robert Schneider; Jessica G Davis; Stephen W Burke; Oheneba Boachie-Adjei; Charles M Mueller; Cathleen L Raggio
Journal:  HSS J       Date:  2007-02

Review 6.  The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.

Authors:  Stefano Stagi; Loredana Cavalli; Salvatore Seminara; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2014-06-07       Impact factor: 2.638

Review 7.  The Musculoskeletal Manifestations of Marfan Syndrome: Diagnosis, Impact, and Management.

Authors:  Lily Pollock; Ashley Ridout; James Teh; Colin Nnadi; Dionisios Stavroulias; Alex Pitcher; Edward Blair; Paul Wordsworth; Tonia L Vincent
Journal:  Curr Rheumatol Rep       Date:  2021-11-26       Impact factor: 4.592

Review 8.  The Multiple Functions of Fibrillin-1 Microfibrils in Organismal Physiology.

Authors:  Keiichi Asano; Anna Cantalupo; Lauriane Sedes; Francesco Ramirez
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 6.208

9.  Assessment of bone mineral status in children with Marfan syndrome.

Authors:  Monica Grover; Nicola Brunetti-Pierri; John Belmont; Kelly Phan; Alyssa Tran; Roman J Shypailo; Kenneth J Ellis; Brendan H Lee
Journal:  Am J Med Genet A       Date:  2012-08-07       Impact factor: 2.802

Review 10.  A scoping review presenting a wide variety of research on paediatric and adolescent patients with Marfan syndrome.

Authors:  Ingeborg Beate Lidal; Trine Bathen; Heidi Johansen; Gry Velvin
Journal:  Acta Paediatr       Date:  2020-02-17       Impact factor: 2.299

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.